Get started
Author

Georgios Katsikas

Observed names: G Katsikas, G. Katsikas, Georgios A. Katsikas
ORCID: 0009-0001-2866-3776
Observed ORCID: 0009-0001-2866-3776
OpenAlex ID: A5018328341
Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
2009 · Magda Nakou, Georgios Katsikas, et al. · Arthritis Research & Therapy · 138
PDF
Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
2018 · Antonis Fanouriakis, Christina Adamichou, et al. · Seminars in Arthritis and Rheumatism · 80
Secondary Cutaneous Nodular AA Amyloidosis in a Patient With Primary Sjögren Syndrome and Celiac Disease
2008 · Georgios A. Katsikas, Maria Maragou, et al. · JCR Journal of Clinical Rheumatology · 21
Post-radiation scleredema adultorum and diffuse eosinophilic fasciitis in the same patient
2010 · E Mylona, S Golfinopoulou, et al. · Scandinavian Journal of Rheumatology · 5
Anasarca and spontaneous intramuscular haemmorhage in a dermatomyositis patient: case report and review of the literature
2024 · Ioannis Xynogalas, Polychroniadis Michail, et al. · Clinical Rheumatology · 1
An underlying systemic disease is common among patients with chronic, treatment resistant urticaria, referred to a tertiary referral centre for autoimmune diseases.
2010 · G Katsikas, Z T Karageorgaki, et al. · PubMed · 1
P1173 Obesity does not affect elective switching from intravenous to subcutaneous infliximab in patients with immune-mediated diseases in clinical remission
2026 · N Viazis, A Karamanakos, et al. · Journal of Crohn s and Colitis
P0946 Switching from intravenous to subcutaneous Infliximab in patients with immune mediated diseases in clinical remission
2025 · N Viazis, A Karamanakos, et al. · Journal of Crohn s and Colitis
Systemic Autoimmune Diseases & Lung Cancer
2024 · Kalliopi Athanassiadi, Evangelia Chatzimihali, et al. · European Respiratory Journal
Severe digital ischaemia as a presentation of antisynthetase syndrome
2024 · Ioannis Xynogalas, Georgios Katsikas, et al. · The Lancet
Pos1097 Rates of Relapses and Serious Adverse Events in Patients With Gpa or Mpa Receiving Rituximab for Maintenance Therapy: a Multicentre, Retrospective Study
2024 · C.G. Gialouri, A. Chalkia, et al. · Annals of the Rheumatic Diseases
FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study
2018 · A. Fanouriakis, C. Adamichou, et al. · Annals of the Rheumatic Diseases
PDF
We-P13:350 Prevalance of metabolic syndrome in a Mediterranean cohort of ankylosing spondylitis patients
2006 · J.A. Papadakis, E.K. Spanakis, et al. · Atherosclerosis Supplements
Works count: 13
Citation count: 246
H-index: 4
I10-index: 3
Year
Topic
Type